In the biggest merger in Danish history, how is culture used as a strategic enabler?

A conversation between Fredrik Alpsten, CEO at Devyser
and Mads Holme, Managing Partner at ReD Associates.

Three essential considerations for leaders to successfully navigate the intricate process of merging corporate cultures.  

Episode 1 of our new podcast, Leading with Perspective, where leading strategic thinker Roger Martin discusses the art of good strategy execution and the role of culture in strategic thinking.

Rikke Kjær Nielsen, partner at EQT Group, on PE as a catalyst for change, the future of impact investment, and building customer understanding into the PE toolbox.

ReD’s Ian Dull and Mad Holme outline four challenges – from consumption to production – that will be important to solve to create a sustainable food system.

Jacob Aarup-Andersen, former CEO of ISS Group and current Carlsberg Group CEO, on making belonging a top priority in a giant people organisation and putting the S in ESG on the leadership agenda.

WorldFish’s interim director general on shifting the climate narrative and using social science to lead organisational change

Ed Whiting (Wellcome Trust’s Director of Strategy) speaks to Mads Holme about the big organisational shifts required to deliver on Wellcome’s new strategy, how deeper, more reciprocal partnerships lead to more long-term solutions, and the importance of human understanding in both effecting change and creating equitable cultures.

A conversation between Britt Meelby Jensen, CEO of AMBU A/S & Mads Holme, Managing Partner at ReD Associates.

Over the past few months, ReD has conducted immersions with a dozen young professionals in Paris, Shanghai, Copenhagen, Stockholm, and NYC across a range of industries to understand their work attitudes, practices, norms, and expectations for employers.

Strategic philanthropy does not have to mean a data-driven approach. Instead it embrace its humanist side.

A conversation with the CEO of Karo on how he made his healthcare company more human-centric.

How getting fans wrong led to chaos in European football, and what we have learned about getting fans right.

With the new reality of pharmaceutical R&D, companies must deliver impact and value. This paper explores how ethnographic research can fill that role in early stages of pharmaceutical clinical trials.

Companies struggle in emerging markets because they underestimate the importance of local culture and social behavior.

Pharma companies are taking steps toward "patient-centric" healthcare by using patient insights to guide drug development and clinical trials.